Aims and Scope
The Open Access Journal of Molecular Medicine (OAJMM) aims to serve as a premier platform for the publication of cutting-edge research at the interface of molecular biology and medicine. Our journal covers a wide range of topics, including but not limited to:
Molecular Basis of Disease: Understanding the molecular mechanisms underlying disease pathogenesis, progression, and treatment response.
Genomic Medicine: Advancements in genomics, transcriptomics, and proteomics with implications for personalized medicine and precision healthcare.
Molecular Diagnostics: Development and validation of molecular biomarkers, diagnostic assays, and imaging techniques for disease detection and monitoring.
Therapeutic Strategies: Novel therapeutic approaches targeting molecular pathways, including small molecules, biologics, gene therapies, and nanomedicine.
Regenerative Medicine: Harnessing the power of molecular biology to develop regenerative therapies for tissue repair and regeneration.
Cancer Biology: Molecular insights into cancer biology, tumor heterogeneity, drug resistance mechanisms, and targeted therapies.
Infectious Diseases: Molecular mechanisms of infectious diseases, host-pathogen interactions, and development of antiviral and antimicrobial agents.
Translational Research: Bridging the gap between basic science discoveries and clinical applications through translational research efforts.
We welcome original research articles, reviews, clinical studies, case reports, and perspectives that contribute to advancing our understanding of molecular mechanisms in health and disease. Join us in the pursuit of scientific discovery and innovation in molecular medicine. Some of the subject areas that the journal focuses on include:
Molecular medicine |
Biomarkers |
Systems biology |
Human experimentation |
Drug development |
Cell signaling |
Bench to bedside |
Precision medicine |
Cell biology |
Bedside to bench |
Personalized medicine |
Cellular mechanisms |
Translational research |
Genomics |
Cellular pathways |
Clinical science |
Proteomics |
Molecular mechanisms of disease |
Basic science |
Pharmacogenomics |
Molecular pathology |
Molecular biology |
Bioinformatics |
Molecular virology |
Medicine |
Data mining |
Molecular immunology |
Molecular mechanisms |
Artificial intelligence |
Molecular hematology |
Disease pathogenesis |
Machine learning |
Molecular cardiology |
Precision medicine |
Targeted therapy |
Molecular neurology |
Personalized healthcare |
Immunotherapy |
Molecular oncology |
Biomarker discovery |
Therapeutic antibodies |
Molecular genetics |
Therapeutic interventions |
Pharmacodynamics |
Molecular therapeutics |
Drug development |
Pharmacokinetics |
Molecular pharmacogenomics |
Genetic medicine |
Drug safety |
Molecular epidemiology |
Pharmacology |
Drug efficacy |
Molecular biomarkers |
Oncology |
Drug toxicity |
Molecular diagnostics |
Cardiology |
Preclinical studies |
Molecular markers |
Neurology |
Animal models |
Molecular immunotherapy |
Immunology |
In vitro studies |
Molecular vaccine development |
Infectious diseases |
In vivo studies |
Molecular gene editing |
Genetics |
Drug discovery |
Molecular drug delivery |
Gene therapy |
High-throughput screening |
Molecular nanomedicine |
Regenerative medicine |
Gene editing |
Molecular targeting |
Diagnostic assays |
Stem cells |
Molecular mechanisms of drug resistance |
Imaging techniques |
Regenerative medicine |
Molecular mechanisms of therapy |
Molecular diagnostics |
Tissue engineering |
Molecular imaging techniques |
Therapeutic targets |
Drug delivery |
Molecular biology techniques |
Signaling pathways |
Nanotechnology |
Molecular cellular therapies |
Molecular pathways |
Microfluidics |
Molecular stem cell therapies |
Disease mechanisms |
Point-of-care testing |
Molecular tissue engineering |
Molecular genetics |
Companion diagnostics |
Molecular regenerative medicine |
Molecular profiling |
Imaging techniques |
Molecular neuroprosthetics |
Molecular imaging |
Magnetic resonance imaging (mri) |
Molecular precision medicine |
Molecular markers |
Computed tomography (ct) |
Molecular personalized medicine translational medicine |
Molecular targets |
Positron emission tomography (pet) |
Clinical trials |
Targeted therapy |
Single-photon emission computed tomography (spect) |
Health information exchange (hie) |
Precision oncology |
Ultrasound |
Clinical decision support systems (cdss) |
Molecular signatures |
Molecular imaging |
Patient-centered care |
Molecular epidemiology |
Optical imaging |
Patient engagement |
Molecular pharmacology |
Radiomics |
Health disparities |
Molecular therapy |
Transcriptomics |
Health outcomes |
Molecular analysis |
Epigenomics |
Health economics |
Molecular diagnostics |
Metabolomics |
Health technology assessment |
Molecular biomarkers |
Proteomics |
Health policy |
Molecular signaling |
Lipidomics |
Health informatics |
Molecular interactions |
Glycomics |
Clinical informatics |
Molecular targets |
Metagenomics |
Public health informatics |
Gene expression profiling |
Microbiome |
Regulatory science |
Genetic mutations |
Pharmacogenetics |
Drug approval process |
Genetic variations |
Clinical genomics |
Clinical trial design |
Genomic medicine |
Clinical proteomics |
Clinical trial management |
Genomic analysis |
Clinical metabolomics |
Pharmacovigilance |
Epigenetics |
Clinical lipidomics |
Adverse drug reactions |
Dna sequencing |
Clinical glycomics |
Drug interactions |
Rna sequencing |
Clinical metagenomics |
Drug repurposing |
Proteomics |
Digital health |
Drug repositioning |
Metabolomics |
Telemedicine |
Biomaterials |
Transcriptomics |
Electronic health records (ehrs) |
Artificial organs |
Health education |
Decision analysis |
Biosensors |
Health literacy |
Health systems research |
Wearable technology |
Health communication |
Health services research |
Smart sensors |
Health promotion, etc. |
Implementation science |
Health monitoring |